III. Novel Endocrine Therapy with Signal Transduction Inhibitors for Hormone Dependent Breast Cancer
Tachibana, K.; Ohtake, T.; Saji, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(13): 2509-2512
2016
ISSN/ISBN: 0385-0684 PMID: 28676614 Document Number: 686628
Document emailed within 1 workday
Related Documents
McKinnon, C. 1999: Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents Idrugs: the Investigational Drugs Journal 2(7): 624-628Dryzhak, V.I. 1989: Estrogen antagonists and inhibitors in hormone therapy of breast cancer Voprosy Onkologii 35(7): 771-778
Iglódi, F. 1989: Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer Therapia Hungarica 37(4): 205-208
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Paciotti, G.F.; Tamarkin, L. 1988: Interleukin-2 differentially affects the proliferation of a hormone-dependent and a hormone-independent human breast cancer cell line in vitro and in vivo Anticancer Research 8(6): 1233-1239
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Jones, R.E.; Defeo-Jones, D.; McAvoy, E.M.; Vuocolo, G.A.; Wegrzyn, R.J.; Haskell, K.M.; Oliff, A. 1991: Mammalian cell lines engineered to identify inhibitors of specific signal transduction pathways Oncogene 6(5): 745-751
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Böhm, M.; Castellano, M.; Agabiti-Rosei, E.; Flesch, M.; Paul, M.; Erdmann, E. 1995: Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction Circulation 92(10): 3006-3013
Jonat, W.; Maass, H. 1987: Endocrine therapy of breast cancer Zentralblatt für Gynakologie 109(10): 617-627
Rugo, H.S. 2019: Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer Clinical Advances in Hematology and Oncology: H&o 17(10): 555-558
Yoshida, M.; Miura, S. 1984: Internal endocrine therapy of breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(5): 989-998
Yang, H.; Shen, F.; Weber, G. 1999: Amplified increase in signal transduction activity in cancer cells Anticancer Research 19(6b): 4983-4988
Taguchi, T. 1998: Adjuvant for breast cancer chemo-endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 453-467
Jakesz, R.; Hausmaninger, H. 1984: Adjuvant endocrine forms of therapy in breast cancer Wiener Klinische Wochenschrift 96(13): 492-499
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
De Luca, A.; Normanno, N. 2009: Endocrine therapy plus zoledronic acid in premenopausal breast cancer New England Journal of Medicine 360(22): 2368-2369; Author Reply 2369-2370